Nutritional Education on Control of Serum Potassium Level in Maintenance Hemodialysis Patients

NCT07632105 | Completed

• 1 other identifier: 36264MS509/2/24
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

The aims of the present study are to determine how face-to-face nutrition education about potassium will affect serum Potassium levels and reduce its complications and improve quality of life for Maintenance Hemodialysis patients at Internal Medicine Department, Tanta University Hospitals.

Conditions

Hemodialysis; Potassium Measurement; Maintenance Dialysis Patients

Keywords

Control; Nutritional Education; Maintenance; Hemodialysis

Outcome Measures

Primary Outcomes (1)

• Nutritional status of hemodialysis patients by anthropometric measurements weight (Kg ) , Height (m2), body mass index

  3 weeks

Secondary Outcomes (1)

• malnutrition inflammation score

  3 weeks

Study Arms (2)

The education group

EXPERIMENTAL

The education group will undergo a 12-week nutritional education program

Behavioral: The education group

control group

PLACEBO COMPARATOR

The control group will receive standard treatment.

Behavioral: The control group

Interventions

The education group BEHAVIORAL

The education group will undergo a 12-week nutritional education program

The education group

The control group BEHAVIORAL

The control group will receive standard treatment.

control group

Eligibility Criteria

• Age: 20 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult older than 18 years of both sex.
• Individuals had been undergoing hemodialysis at least three times a week for more than six months.
• Individuals have a serum potassium level ≥5.5 mEq/L.
• Able to provide an informed consent.
• Willingness to adhere to the study protocol for its entire duration.
• Absence of any planned medical procedures that might interfere with study participation during the study period.

You may not qualify if:

• Individuals who had received education on potassium previously. Patients who took potassium-lowering drugs.
• Individuals whose serum potassium level was below 5.5 mEq/L during the month before the study.
• Presence of Cardiovascular complications or any event from multiple co-morbid metabolic diseases like pulmonary edema, congestive heart failure, or coma.

Sponsors & Collaborators

• Tanta University: lead

Study Sites (1)

Tanta University

Tanta, Egypt

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident of Internal Medicine

Study Record Dates

• First Submitted: May 25, 2026
• First Posted: June 8, 2026
• Study Start: April 30, 2024
• Primary Completion: April 30, 2025
• Study Completion: April 30, 2025
• Last Updated: June 8, 2026

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF

Locations

EG (1)